Binge toluene exposure in pregnancy and pre-weaning developmental consequences in rats

Neurotoxicology and Teratology

Volumn 38, Issue , 2013, Pages 29-35

  Bowen, Scott E ^a,b   Hannigan, John H ^a,b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gestational toluene exposure; Rats; Toluene

Indexed keywords

TOLUENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONGENITAL MALFORMATION; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; FEMALE; GROWTH RETARDATION; MALE; NEWBORN DEATH; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SUBSTANCE ABUSE; TERATOGENICITY;

GESTATIONAL TOLUENE EXPOSURE; RATS; TOLUENE;

ABNORMALITIES, DRUG-INDUCED; ADMINISTRATION, INHALATION; ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; SOLVENTS; TOLUENE;

EID: 84877917664     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2013.04.002     Document Type: Article

References (56)

1. Abbey H., Howard E. Statistical procedure in developmental studies on species with multiple offspring. Dev Psychobiol 1973, 6:329-335.
2. ACGIH Documentation of the threshold limit values and biological exposure indices. American conference of governmental industrial hygienists 1991, 1576. Cincinnati, OH.
3. Adams J. Methods in behavioral teratology 1986, Plenum Press, Inc., New York.
4. Arai H., Yamada M., Miyake S., Yamashita S., Iwamoto H., Aida N., et al. Two cases of toluene embryopathy with severe motor and intellectual disabilities syndrome. No To Hattatsu 1997, 29:361-366.
5. Arnold G.L., Kirby R.S., Langendoerfer S., Wilkins-Haug L. Toluene embryopathy: clinical delineation and developmental follow-up. Pediatrics 1994, 93:216-220.
6. Beauvais F., Wayman J.C., Jumper-Thurman P., Plested B., Helm H. Inhalant abuse among American Indian, Mexican American, and non-Latino white adolescents. Am J Drug Alcohol Abuse 2002, 28:171-187.
7. Bowen S.E. Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome. Subst Use Misuse 2011, 46:68-72.
8. Bowen S.E., Daniel J., Balster R.L. Deaths associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend 1999, 53:239-245.
9. Bowen S.E., Batis J.C., Mohammadi M.H., Hannigan J.H. Abuse pattern of gestational toluene exposure and early postnatal development in rats. Neurotoxicol Teratol 2005, 27:105-116.
10. Bowen S.E., Hannigan J.H., Irtenkauf S. Maternal and fetal blood and organ toluene levels in rats following acute and repeated binge inhalation exposure. Reprod Toxicol 2007, 24:343-352.
11. Bowen S.E., Irtenkauf S., Hannigan J.H., Stefanski A.L. Alterations in rat fetal morphology following abuse patterns of toluene exposure. Reprod Toxicol 2009, 27:161-169.
12. Bukowski J.A. Review of the epidemiological evidence relating toluene to reproductive outcomes. Regul Toxicol Pharmacol 2001, 33:147-156.
13. Dell C.A., Gust S.W., MacLean S. Global issues in volatile substance misuse. Subst Use Misuse 2011, 46:1-7.
14. Devathasan G., Low D., Teoh P.C., Wan S.H., Wong P.K. Complications of chronic glue (toluene) abuse in adolescents. Aust N Z J Med 1984, 14:39-43.
15. Fornazzari L., Wilkinson D.A., Kapur B.M., Carlen P.L. Cerebellar, cortical and functional impairment in toluene abusers. Acta Neurol Scand 1983, 67:319-329.
16. Fornazzari L., Riley D., Wu P., Carlen P.L. Toluene abuse and neurologic impairment. Neurology 1987, 37:356.
17. Goodwin T.M. Toluene abuse and renal tubular acidosis in pregnancy. Obstet Gynecol 1988, 71:715-718.
18. Goodwin J.M., Geil C., Grodner B., Metrick S. Inhalant abuse, pregnancy, and neglected children. Am J Psychiatry 1981, 138:1126.
19. Gospe S.M., Zhou S.S. Toluene abuse embryopathy: longitudinal neurodevelopmental effects of prenatal exposure to toluene in rats. Reprod Toxicol 1998, 12:119-126.
20. Gospe S.M., Zhou S.S. Prenatal exposure to toluene results in abnormal neurogenesis and migration in rat somatosensory cortex. Pediatr Res 2000, 47:362-368.
21. Gospe S.M., Saeed D.B., Zhou S.S., Zeman F.J. The effects of high-dose toluene on embryonic development in the rat. Pediatr Res 1994, 36:811-815.
22. Gospe S.M., Zhou S.S., Saeed D.B., Zeman F.J. Development of a rat model of toluene-abuse embryopathy. Pediatr Res 1996, 40:82-87.
23. Greenberg M.M. The central nervous system and exposure to toluene: a risk characterization. Environ Res 1997, 72:1-7.
24. Hannigan J.H., Bowen S.E. Reproductive toxicology and teratology of abused toluene. Syst Biol Reprod Med 2010, 56:184-200.
25. Hersh J.H. Toluene embryopathy: two new cases. J Med Genet 1989, 26:333-337.
26. Hersh J.H., Podruch P.E., Rogers G., Weisskopf B. Toluene embryopathy. J Pediatr 1985, 106:922-927.
27. Hougaard K.S., Hass U., Lund S.P., Simonsen L. Effects of prenatal exposure to toluene on postnatal development and behavior in rats. Neurotoxicol Teratol 1999, 21:241-250.
28. Howard M.O., Bowen S.E., Garland E.L., Perron B.E., Vaughn M.G. Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract 2011, 6:18-31.
29. Hunter A.G., Thompson D., Evans J.A. Is there a fetal gasoline syndrome?. Teratology 1979, 20:75-79.
30. Jarosz P.A., Fata E., Bowen S.E., Jen K.L., Coscina D.V. Effects of abuse pattern of gestational toluene exposure on metabolism, feeding and body composition. Physiol Behav 2008, 93:984-993.
31. Jones H.E., Balster R.L. Neurobehavioral consequences of intermittent prenatal exposure to high concentrations of toluene. Neurotoxicol Teratol 1997, 19:305-313.
32. Jones H.E., Balster R.L. Inhalant abuse in pregnancy. Obstet Gynecol Clin North Am 1998, 25:153-167.
33. Keppel G. Design and analysis: a researcher's handbook 1991, Prentice Hall, Inc., Upper Saddle River, New Jersey. 3rd ed.
34. King M.D., Day R.E., Oliver J.S., Lush M., Watson J.M. Solvent encephalopathy. Br Med J (Clin Res Ed) 1981, 283:663-665.
35. Klaassen C.D. Distribution, excretion and absorption. Casarett and Doull's toxicology: the basic science of poisons 1986, 33-63. Macmillan, New York. 3rd ed. C.D. Klaassen, M.O. Amdur, J. Doull (Eds.).
36. Kuczkowski K.M. The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol 2007, 19:578-585.
37. Kurtzman T.L., Otsuka K.N., Wahl R.A. Inhalant abuse by adolescents. J Adolesc Health 2001, 28:170-180.
38. Lazar R.B., Ho S.U., Melen O., Daghestani A.N. Multifocal central nervous system damage caused by toluene abuse. Neurology 1983, 33:1337-1340.
39. Malm G., Lying-Tunell U. Cerebellar dysfunction related to toluene sniffing. Acta Neurol Scand 1980, 62:188-190.
40. Marjot R., McLeod A.A. Chronic non-neurological toxicity from volatile substance abuse. Hum Toxicol 1989, 8:301-306.
41. Maxwell J.C. Deaths related to the inhalation of volatile substances in Texas: 1988-1998. Am J Drug Alcohol Abuse 2001, 27:689-697.
42. McGarvey E.L., Clavet G.J., Mason W., Waite D. Adolescent inhalant abuse: environments of use. Am J Drug Alcohol Abuse 1999, 25:731-741.
43. Medina-Mora M.E., Real T. Epidemiology of inhalant use. Curr Opin Psychiatry 2008, 21:247-251.
44. Pearson M.A., Hoyme H.E., Seaver L.H., Rimsza M.E. Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 1994, 93:211-215.
45. Rosenberg N.L., Kleinschmidt-DeMasters B.K., Davis K.A., Dreisbach J.N., Hormes J.T., Filley C.M. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988, 23:611-614.
46. SAMHSA The NSDUH report March 15, 2007 patterns and trends in inhalant use by adolescent males and females:2002-2005. Substance abuse and mental health services administration, U.S. Department of Health and Human Services, No. NSDUH07-0315 2007.
47. SAMHSA The NSDUH report March 13, 2008 inhalant use across the adolescent years 2008, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD, [March 13, 2008].
48. SAMHSA Results from the 2008 National Survey on drug use and health: national findings. NSDUH Series H-36, HHS Publication No. SMA 09-4434 2009, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
49. SAMHSA Data spotlight: adults represent the majority of inhalant treatment admissions. Substance Abuse and Mental Health Services Administration, Office of Applied Studies 2011, [(March 17, 2011), Rockville, MD].
50. SAMHSA Results from the 2010 National Survey on drug use and health: summary of national findings, NSDUH Series H-41, HHS publication no. (SMA) 11-4658 2011, Substance Abuse and Mental Health Services Administration, Rockville, MD.
51. SAMHSA Results from the 2011 National Survey on drug use and health: summary of national findings 2012, Substance Abuse and Mental Health Services Administration, Rockville, MD.
52. Thiel R., Chahoud I. Postnatal development and behaviour of Wistar rats after prenatal toluene exposure. Arch Toxicol 1997, 71:258-265.
53. Toutant C., Lippmann S. Fetal solvents syndrome. Lancet 1979, 1:1356.
54. Warner R., Ritchie H.E., Woodman P., Oakes D., Pourghasem M. The effect of prenatal exposure to a repeat high dose of toluene in the fetal rat. Reprod Toxicol 2008, 26:267-272.
55. Wilkins-Haug L., Gabow P.A. Toluene abuse during pregnancy: obstetric complications and perinatal outcomes. Obstet Gynecol 1991, 77:504-509.
56. York R.G., Sowry B.M., Hastings L., Manson J.M. Evaluation of teratogenicity and neurotoxicity with maternal inhalation exposure to methyl chloroform. J Toxicol Environ Health 1982, 9:251-266.